Literature DB >> 19960264

Psychosomatic aspects of Cushing's syndrome.

Nicoletta Sonino1, Francesco Fallo, Giovanni A Fava.   

Abstract

There has been growing interest in the psychosocial aspects of Cushing's syndrome, such as the role of life stress as a pathogenetic factor, the association with affective disorders, and the presence of residual symptoms after treatment. Interestingly, a temporal relationship between stressful life events and disease onset is relevant only to pituitary-dependent Cushing's disease, and not to the pituitary-independent forms. A number of psychiatric and psychological disturbances may be associated with the active hypercortisolemic state, regardless of its etiology. Within the high frequency of mood disorders (about 60%), major depression is the most common complication. Other psychopathological aspects include mania, anxiety disorders, psychological symptoms (demoralization, irritable mood, somatization) and cognitive impairment. Cognitive symptoms are associated with brain abnormalities (mainly loss of brain volume). Quality of life may be seriously compromised during both active and post-treatment phases. Long-standing hypercortisolism may imply a degree of irreversibility of the pathological process. Recovery, thus, may be delayed and be influenced by highly individualized affective responses. Outcomes of Cushing's syndrome treatment are not fully satisfactory. Within its great complexity, a conceptual shift from a merely biomedical care to a psychosomatic consideration of the person and his/her quality of life appears to be necessary to improve effectiveness. It is time to translate the research evidence that has accumulated into clinical practice initiatives. To patients who show persistence or even worsening of psychological distress upon adequate endocrine treatment psychiatric/psychological interventions should be readily available. Applying interdisciplinary expertise and addressing the needs for rehabilitation would markedly improve final outcome.

Entities:  

Mesh:

Year:  2010        PMID: 19960264     DOI: 10.1007/s11154-009-9123-7

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  55 in total

Review 1.  Psychological aspects of endocrine disease.

Authors:  N Sonino; G A Fava
Journal:  Clin Endocrinol (Oxf)       Date:  1998-07       Impact factor: 3.478

2.  Clinical correlates of major depression in Cushing's disease.

Authors:  N Sonino; G A Fava; A R Raffi; M Boscaro; F Fallo
Journal:  Psychopathology       Date:  1998 Nov-Dec       Impact factor: 1.944

3.  The prevalence and characteristic features of cyclicity and variability in Cushing's disease.

Authors:  Krystallenia I Alexandraki; Gregory A Kaltsas; Andrea M Isidori; Scott A Akker; William M Drake; Shern L Chew; John P Monson; G Michael Besser; Ashley B Grossman
Journal:  Eur J Endocrinol       Date:  2009-03-16       Impact factor: 6.664

4.  A psychoneuroendocrinology service.

Authors:  Nicoletta Sonino; Pio Peruzzi
Journal:  Psychother Psychosom       Date:  2009-08-27       Impact factor: 17.659

Review 5.  Salivary cortisol as a biomarker in stress research.

Authors:  Dirk H Hellhammer; Stefan Wüst; Brigitte M Kudielka
Journal:  Psychoneuroendocrinology       Date:  2008-12-18       Impact factor: 4.905

6.  Fifty years with the Hamilton scales for anxiety and depression. A tribute to Max Hamilton.

Authors:  P Bech
Journal:  Psychother Psychosom       Date:  2009-04-28       Impact factor: 17.659

7.  Personality characteristics and quality of life in patients treated for Cushing's syndrome.

Authors:  Nicoletta Sonino; Stefano Bonnini; Francesco Fallo; Marco Boscaro; Giovanni A Fava
Journal:  Clin Endocrinol (Oxf)       Date:  2006-03       Impact factor: 3.478

8.  Location of ectopic adrenocortical hormone-secreting tumors causing Cushing's syndrome in the paranasal sinuses.

Authors:  Israel Hodish; Thomas J Giordano; Monica N Starkman; David E Schteingart
Journal:  Head Neck       Date:  2009-05       Impact factor: 3.147

9.  Quality of life in patients with a pituitary adenoma.

Authors:  Michelle D Johnson; C J Woodburn; Mary Lee Vance
Journal:  Pituitary       Date:  2003-09       Impact factor: 4.107

Review 10.  Increasing psychological well-being and resilience by psychotherapeutic methods.

Authors:  Giovanni A Fava; Elena Tomba
Journal:  J Pers       Date:  2009-10-06
View more
  25 in total

1.  White matter involvement on DTI-MRI in Cushing's syndrome relates to mood disturbances and processing speed: a case-control study.

Authors:  Patricia Pires; Alicia Santos; Yolanda Vives-Gilabert; Susan M Webb; Aitor Sainz-Ruiz; Eugenia Resmini; Iris Crespo; Manel de Juan-Delago; Beatriz Gómez-Anson
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

3.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome.

Authors:  Andrea Rebellato; Andrea Grillo; Francesca Dassie; Nicoletta Sonino; Pietro Maffei; Chiara Martini; Agostino Paoletta; Bruno Fabris; Renzo Carretta; Francesco Fallo
Journal:  Endocrine       Date:  2014-01-10       Impact factor: 3.633

Review 4.  Managing Cushing's disease: the state of the art.

Authors:  Annamaria Colao; Marco Boscaro; Diego Ferone; Felipe F Casanueva
Journal:  Endocrine       Date:  2014-01-11       Impact factor: 3.633

5.  Long-term follow-up on Cushing disease patient after transsphenoidal surgery.

Authors:  Insook Jeong; Moonyeon Oh; Ja Hye Kim; Ja Hyang Cho; Jin-Ho Choi; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-09-30

6.  Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease.

Authors:  Sonja Siegel; Monika Milian; Bernadette Kleist; Tsambika Psaras; Maria Tsiogka; Dagmar Führer; Maria Koltowska-Häggström; Jürgen Honegger; Oliver Müller; Ulrich Sure; Christa Menzel; Michael Buchfelder; Ilonka Kreitschmann-Andermahr
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

7.  Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).

Authors:  X Badia; M Roset; E Valassi; H Franz; A Forsythe; S M Webb
Journal:  Qual Life Res       Date:  2013-03-29       Impact factor: 4.147

8.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; M Hassan Murad; John Newell-Price; Martin O Savage; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2015-07-29       Impact factor: 5.958

9.  Evaluation of depression, quality of life and body image in patients with Cushing's disease.

Authors:  Nilufer Alcalar; Sedat Ozkan; Pinar Kadioglu; Ozlem Celik; Penbe Cagatay; Baris Kucukyuruk; Nurperi Gazioglu
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

10.  A proposed role for glucocorticoids in mediating dopamine-dependent cue-reward learning.

Authors:  Sofia A Lopez; Shelly B Flagel
Journal:  Stress       Date:  2020-06-11       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.